Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran
Insights
Hepatitis C virus co-infection is common in patients with human immunodeficiency virus, with imprisonment and drug injection addiction being significant risk factors. This study highlights the need for targeted interventions for these vulnerable populations.
Area of Science:
- Infectious Diseases
- Hepatology
- Virology
Background:
- Hepatitis B and C virus (HBV & HCV) infections are significant global health concerns.
- Human immunodeficiency virus (HIV)-positive individuals are at increased risk of HBV and HCV co-infections.
- Understanding risk factors for these co-infections is crucial for effective management and prevention.
Purpose of the Study:
- To determine the prevalence of hepatitis B and C virus co-infections among HIV-positive patients.
- To identify demographic and behavioral risk factors associated with HBV and HCV co-infections in this population.
Main Methods:
- A cross-sectional study was conducted with 165 HIV-positive patients in Kerman, Iran.
- Data on demographics and high-risk behaviors were collected.
- Hepatitis C antibody and hepatitis B surface antigen were tested using ELISA; statistical analysis was performed using SPSS 18.
Main Results:
- The prevalence of HCV antibody was 73.9% and HBsAg was 3.6%.
- Triple co-infection (HIV, HCV, HBV) was found in 1.8% of patients.
- History of imprisonment (OR=17.5) and drug injection addiction (OR=15.3) were strongly associated with HCV co-infection.
Conclusions:
- HCV and HIV co-infection is highly prevalent in the studied population.
- Imprisonment and drug injection addiction are significant risk factors for HCV/HIV co-infection.
- These findings underscore the importance of targeted screening and prevention strategies.
Objective:
To determine the risk factors and frequency of hepatitis B and C virus co-infections in human immunodeficiency virus-positive patients.
Methods:
The cross-sectional study was conducted at the Control of Diseases Centre of Kerman Medical University, southern Iran, between May and December 2011. Demographic features and history of high-risk behaviours were evaluated in 165 patients positive for human immunodeficiency virus. Third-generation hepatitis C virus antibody and hepatitis B surface antigen tests were performed by enzyme-linked immunosorbent assay method. SPSS 18 was used for statistical analysis.
Results:
Out of the 165 patients, 136 (82.4%) were male and 29 (17.6%) were female. The mean age of the subjects was 40.4 +/- 9 years. Positive hepatitis C antibody was found in 122 (73.9%) and positive hepatitis B surface antigen was present in 6 (3.6%). Frequency of all three viruses co-infection was 3 (1.8%). History of imprisonment (OR = 17.5; 95% CI: 7.1-43.1) and drug injection addiction (OR = 15.3; 95% CI: 6.4-36.1) were the most significant risk factors involved in hepatitis C virus co-infection.
Conclusion:
Seroprevalence of hepatitis C virus and human immunodeficiency virus co-infection was high and it was strongly related to history of imprisonment and drug injection addiction.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles
Infectious Diseases and Their Occurrence

